4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide

C44H51N9O5S — CID 174299583

IUPAC4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide
SMILESCNC(=O)CCC(C=O)N1Cc2ccc(N3CCC(CN4CCC5(CC4)CN(c4cccc(SNc6noc7cc(Cn8cccn8)cc(OC)c67)c4)C5)C3)cc2C1=O
InChIInChI=1S/C44H51N9O5S/c1-45-40(55)10-9-35(27-54)53-26-32-7-8-34(22-37(32)43(53)56)50-16-11-30(24-50)23-49-17-12-44(13-18-49)28-51(29-44)33-5-3-6-36(21-33)59-48-42-41-38(57-2)19-31(20-39(41)58-47-42)25-52-15-4-14-46-52/h3-8,14-15,19-22,27,30,35H,9-13,16-18,23-26,28-29H2,1-2H3,(H,45,55)(H,47,48)
InChIKeySVLDEZAUCLYWRW-UHFFFAOYSA-N
MW818.02 g/mol
LogP5.68
Rot. Bonds15

About 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide

4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide (PubChem CID 174299583) has the molecular formula C44H51N9O5S and a molecular weight of 818.02 g/mol. Its IUPAC name is 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide.

Molecular Properties

Compound Name4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide
PubChem CID174299583
Molecular FormulaC44H51N9O5S
Molecular Weight818.02 g/mol
Exact Mass817.37
IUPAC Name4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide
SMILESCNC(=O)CCC(C=O)N1Cc2ccc(N3CCC(CN4CCC5(CC4)CN(c4cccc(SNc6noc7cc(Cn8cccn8)cc(OC)c67)c4)C5)C3)cc2C1=O
InChIInChI=1S/C44H51N9O5S/c1-45-40(55)10-9-35(27-54)53-26-32-7-8-34(22-37(32)43(53)56)50-16-11-30(24-50)23-49-17-12-44(13-18-49)28-51(29-44)33-5-3-6-36(21-33)59-48-42-41-38(57-2)19-31(20-39(41)58-47-42)25-52-15-4-14-46-52/h3-8,14-15,19-22,27,30,35H,9-13,16-18,23-26,28-29H2,1-2H3,(H,45,55)(H,47,48)
InChIKeySVLDEZAUCLYWRW-UHFFFAOYSA-N
XLogP5.68
TPSA141.31 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds15
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500818.02
LogP ≤ 55.68
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_D(198)', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide?
The IUPAC name of 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide (CID 174299583) is 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide.
What is the SMILES notation for 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide?
The canonical SMILES for 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide is CNC(=O)CCC(C=O)N1Cc2ccc(N3CCC(CN4CCC5(CC4)CN(c4cccc(SNc6noc7cc(Cn8cccn8)cc(OC)c67)c4)C5)C3)cc2C1=O.
What is the InChIKey of 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide?
The InChIKey is SVLDEZAUCLYWRW-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H51N9O5S/c1-45-40(55)10-9-35(27-54)53-26-32-7-8-34(22-37(32)43(53)56)50-16-11-30(24-50)23-49-17-12-44(13-18-49)28-51(29-44)33-5-3-6-36(21-33)59-48-42-41-38(57-2)19-31(20-39(41)58-47-42)25-52-15-4-14-46-52/h3-8,14-15,19-22,27,30,35H,9-13,16-18,23-26,28-29H2,1-2H3,(H,45,55)(H,47,48).
What are the key properties of 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide?
4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide has a molecular weight of 818.02 g/mol, XLogP of 5.68, 15 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-[3-[[2-[3-[[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]amino]sulfanylphenyl]-2,7-diazaspiro[3.5]nonan-7-yl]methyl]pyrrolidin-1-yl]-3-oxo-1H-isoindol-2-yl]-N-methyl-5-oxopentanamide is sourced from PubChem (CID 174299583), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).